You Deserve the Most Accurate Autoimmune Testing Available

 

You Deserve The Most Accurate Autoimmune Testing Available


 

AVISE Rheumatology Testing is the Most Accurate Solution for Actionable Results.

Backed by science and evidence, AVISE Lupus powered by CB-CAPs, has been shown to increase physician confidence in both ruling in and ruling out SLE, leading to treatment initiation in positive patients and higher patient-reported outcomes.

Actionable results where conventional testing is negative

Increased odds for SLE diagnosis when AVISE Lupus is positive and anti-dsDNA is negative.Alexander RV, et al. Lupus Sci Med. 2021 Jul;8(1):e000528. Doi: 10.1136/lupus-2021

Reduction in tests used

Costs for diagnostic tests decrease twice as much compared to patients tested with General Reference Lab tests in the year following AVISE or General Reference Lab testing.Data on file

Earlier initiation of therapy that mitigates disease progression

Increased odds of initiation when AVISE is positive and anti-dsDNA negative.Alexander RV, et al. Lupus Sci Med. 2021 Jul;8(1):e000528. Doi: 10.1136/lupus-2021

Reduction in healthcare costs

$2,000 in savings per eligible patient.Clarke et al. ACR Open Rheumatology. 2020 Doi: 10.1002/acr2.11177

Image
Image

Manage every step of your patient’s lupus journey with the AVISE® complete portfolio of tests

AVISE Diagnose

Diagnose the right autoimmune disease with confidence

AVISE Prognose

Prognose which organs may be under attack

AVISE Monitor

Monitor disease progression with unique serological markers

Image

When you need accuracy, you need AVISE testing

AVISE
Testing
General Reference
Lab Testing

Take control over your patient’s autoimmune disease. Visit AviseTest.com/tests or call 888.452.1522.

Image

Request a Consultation


Would you like to learn more about AVISE testing or request a technical consultation about a test report?

Contact us using the form below and a representative will contact you shortly.


  • This field is for validation purposes and should be left unchanged.

Image